ADVERTISEMENT
GSK Pharma Q3 Results Review - General Medicines, Controlled Costs Fuel Earnings Growth: Motilal Oswal
While the general medicines category bolstered GSK Phama’s performance, vaccines continue to offset it to some extent.
08 Feb 2023, 08:52 AM IST 
Save
A view shows GlaxoSmithKline headquarters in London, Britain. (Source: Reuters/Hannah McKay)
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
